title: Is methotrexate effective in ankylosing spondylitis?
authors.forename: B
authors.initials: B
authors.lastname: Roychowdhury
authors.forename: S
authors.initials: S
authors.lastname: Bintley-Bagot
authors.forename: D Y
authors.initials: DY
authors.lastname: Bulgen
authors.forename: R N
authors.initials: RN
authors.lastname: Thompson
authors.forename: E J
authors.initials: EJ
authors.lastname: Tunn
authors.forename: R J
authors.initials: RJ
authors.lastname: Moots
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D018501:Antirheumatic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage* / Q000009:adverse effects; D008875:Middle Aged; D011336:Probability; D012016:Reference Values; D012720:Severity of Illness Index; D013167:Spondylitis, Ankylosing / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome; D006113:United Kingdom
chemical_list: D018501:Antirheumatic Agents; D008727:Methotrexate